Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study (2022)
https://pubmed.ncbi.nlm.nih.gov/35368376/

Successful Evaluation of Spinal Mobility Measurements With the Epionics SPINE Device in Patients With Axial Spondyloarthritis Compared to Controls (2021)
https://pubmed.ncbi.nlm.nih.gov/34393107/

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/31604704/

Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study (2020)
https://pubmed.ncbi.nlm.nih.gov/32378070/

Sensitivity and Specificity of Autoantibodies Against CD74 in Nonradiographic Axial Spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30418704/

Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis. (2016)
https://pubmed.ncbi.nlm.nih.gov/26865599/

Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety (2016)
https://pubmed.ncbi.nlm.nih.gov/27049733/

Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis. (2016)
https://pubmed.ncbi.nlm.nih.gov/26865599/